 | • レポートコード：GIR-105X14540 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、RNAワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。RNAワクチンの種類別市場規模（個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン）、用途別市場規模（感染症、がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・RNAワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン ・用途別分析2016年-2026年：感染症、がん、その他 ・RNAワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・RNAワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・RNAワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・RNAワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・RNAワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The RNA Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global RNA Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global RNA Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
RNA Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Market segment by Application can be divided into
Infectious Disease
Cancer
Other
The key market players for global RNA Vaccines market are listed below:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 RNA Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global RNA Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global RNA Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Global RNA Vaccines Market Size & Forecast
1.4.1 Global RNA Vaccines Sales in Value (2016-2026))
1.4.2 Global RNA Vaccines Sales in Volume (2016-2026)
1.4.3 Global RNA Vaccines Price by Type (2016-2026) & (USD/Dose)
1.5 Global RNA Vaccines Production Capacity Analysis
1.5.1 Global RNA Vaccines Total Production Capacity (2016-2026)
1.5.2 Global RNA Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 RNA Vaccines Market Drivers
1.6.2 RNA Vaccines Market Restraints
1.6.3 RNA Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business
2.1.3 Moderna Therapeutics RNA Vaccines Product and Services
2.1.4 Moderna Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac RNA Vaccines Product and Services
2.2.4 CureVac RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Translate Bio
2.3.1 Translate Bio Details
2.3.2 Translate Bio Major Business
2.3.3 Translate Bio RNA Vaccines Product and Services
2.3.4 Translate Bio RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech RNA Vaccines Product and Services
2.4.4 BioNTech RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sangamo Therapeutics
2.5.1 Sangamo Therapeutics Details
2.5.2 Sangamo Therapeutics Major Business
2.5.3 Sangamo Therapeutics RNA Vaccines Product and Services
2.5.4 Sangamo Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business
2.6.3 Argos Therapeutics RNA Vaccines Product and Services
2.6.4 Argos Therapeutics RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 In-Cell-Art
2.7.1 In-Cell-Art Details
2.7.2 In-Cell-Art Major Business
2.7.3 In-Cell-Art RNA Vaccines Product and Services
2.7.4 In-Cell-Art RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 eTheRNA
2.8.1 eTheRNA Details
2.8.2 eTheRNA Major Business
2.8.3 eTheRNA RNA Vaccines Product and Services
2.8.4 eTheRNA RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Ethris
2.9.1 Ethris Details
2.9.2 Ethris Major Business
2.9.3 Ethris RNA Vaccines Product and Services
2.9.4 Ethris RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Tiba Biotechnology
2.10.1 Tiba Biotechnology Details
2.10.2 Tiba Biotechnology Major Business
2.10.3 Tiba Biotechnology RNA Vaccines Product and Services
2.10.4 Tiba Biotechnology RNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 RNA Vaccines Sales by Manufacturer
3.1 Global RNA Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global RNA Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in RNA Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 RNA Vaccines Manufacturer Market Share
3.4.2 Top 6 RNA Vaccines Manufacturer Market Share
3.5 Global RNA Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and RNA Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global RNA Vaccines Market Size by Region
4.1.1 Global RNA Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global RNA Vaccines Revenue by Region (2016-2026)
4.2 North America RNA Vaccines Revenue (2016-2026)
4.3 Europe RNA Vaccines Revenue (2016-2026)
4.4 Asia-Pacific RNA Vaccines Revenue (2016-2026)
4.5 South America RNA Vaccines Revenue (2016-2026)
4.6 Middle East and Africa RNA Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global RNA Vaccines Sales in Volume by Type (2016-2026)
5.2 Global RNA Vaccines Revenue by Type (2016-2026)
5.3 Global RNA Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global RNA Vaccines Sales in Volume by Application (2016-2026)
6.2 Global RNA Vaccines Revenue by Application (2016-2026)
6.3 Global RNA Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America RNA Vaccines Sales by Type (2016-2026)
7.2 North America RNA Vaccines Sales by Application (2016-2026)
7.3 North America RNA Vaccines Market Size by Country
7.3.1 North America RNA Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America RNA Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe RNA Vaccines Sales by Type (2016-2026)
8.2 Europe RNA Vaccines Sales by Application (2016-2026)
8.3 Europe RNA Vaccines Market Size by Country
8.3.1 Europe RNA Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe RNA Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific RNA Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific RNA Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific RNA Vaccines Market Size by Region
9.3.1 Asia-Pacific RNA Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific RNA Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America RNA Vaccines Sales by Type (2016-2026)
10.2 South America RNA Vaccines Sales by Application (2016-2026)
10.3 South America RNA Vaccines Market Size by Country
10.3.1 South America RNA Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America RNA Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa RNA Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa RNA Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa RNA Vaccines Market Size by Country
11.3.1 Middle East & Africa RNA Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa RNA Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 RNA Vaccines Typical Distributors
12.3 RNA Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global RNA Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global RNA Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Moderna Therapeutics Major Business
Table 5. Moderna Therapeutics RNA Vaccines Product and Services
Table 6. Moderna Therapeutics RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. CureVac Basic Information, Manufacturing Base and Competitors
Table 8. CureVac Major Business
Table 9. CureVac RNA Vaccines Product and Services
Table 10. CureVac RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 12. Translate Bio Major Business
Table 13. Translate Bio RNA Vaccines Product and Services
Table 14. Translate Bio RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. BioNTech Basic Information, Manufacturing Base and Competitors
Table 16. BioNTech Major Business
Table 17. BioNTech RNA Vaccines Product and Services
Table 18. BioNTech RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Sangamo Therapeutics Major Business
Table 21. Sangamo Therapeutics RNA Vaccines Product and Services
Table 22. Sangamo Therapeutics RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Argos Therapeutics Major Business
Table 25. Argos Therapeutics RNA Vaccines Product and Services
Table 26. Argos Therapeutics RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 28. In-Cell-Art Major Business
Table 29. In-Cell-Art RNA Vaccines Product and Services
Table 30. In-Cell-Art RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. eTheRNA Basic Information, Manufacturing Base and Competitors
Table 32. eTheRNA Major Business
Table 33. eTheRNA RNA Vaccines Product and Services
Table 34. eTheRNA RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Ethris Basic Information, Manufacturing Base and Competitors
Table 36. Ethris Major Business
Table 37. Ethris RNA Vaccines Product and Services
Table 38. Ethris RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 40. Tiba Biotechnology Major Business
Table 41. Tiba Biotechnology RNA Vaccines Product and Services
Table 42. Tiba Biotechnology RNA Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global RNA Vaccines Sales by Manufacturer (2019-2021e) & (K Doses)
Table 44. Global RNA Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in RNA Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global RNA Vaccines Production Capacity by Company, (K Doses): 2020 VS 2021
Table 47. Head Office and RNA Vaccines Production Site of Key Manufacturer
Table 48. Global RNA Vaccines Sales by Region (2016-2021e) & (K Doses)
Table 49. Global RNA Vaccines Sales by Region (2021-2026) & (K Doses)
Table 50. Global RNA Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global RNA Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 52. Global RNA Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 53. Global RNA Vaccines Sales by Type (2021-2026) & (K Doses)
Table 54. Global RNA Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global RNA Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 56. Global RNA Vaccines Price by Type (2016-2021e) & (USD/Dose)
Table 57. Global RNA Vaccines Price by Type (2021-2026) & (USD/Dose)
Table 58. Global RNA Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 59. Global RNA Vaccines Sales by Application (2021-2026) & (K Doses)
Table 60. Global RNA Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global RNA Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 62. Global RNA Vaccines Price by Application (2016-2021e) & (USD/Dose)
Table 63. Global RNA Vaccines Price by Application (2021-2026) & (USD/Dose)
Table 64. North America RNA Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 65. North America RNA Vaccines Sales by Country (2021-2026) & (K Doses)
Table 66. North America RNA Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America RNA Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 68. North America RNA Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 69. North America RNA Vaccines Sales by Type (2021-2026) & (K Doses)
Table 70. North America RNA Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 71. North America RNA Vaccines Sales by Application (2021-2026) & (K Doses)
Table 72. Europe RNA Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 73. Europe RNA Vaccines Sales by Country (2021-2026) & (K Doses)
Table 74. Europe RNA Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe RNA Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe RNA Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 77. Europe RNA Vaccines Sales by Type (2021-2026) & (K Doses)
Table 78. Europe RNA Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 79. Europe RNA Vaccines Sales by Application (2021-2026) & (K Doses)
Table 80. Asia-Pacific RNA Vaccines Sales by Region (2016-2021e) & (K Doses)
Table 81. Asia-Pacific RNA Vaccines Sales by Region (2021-2026) & (K Doses)
Table 82. Asia-Pacific RNA Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific RNA Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific RNA Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 85. Asia-Pacific RNA Vaccines Sales by Type (2021-2026) & (K Doses)
Table 86. Asia-Pacific RNA Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 87. Asia-Pacific RNA Vaccines Sales by Application (2021-2026) & (K Doses)
Table 88. South America RNA Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 89. South America RNA Vaccines Sales by Country (2021-2026) & (K Doses)
Table 90. South America RNA Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America RNA Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 92. South America RNA Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 93. South America RNA Vaccines Sales by Type (2021-2026) & (K Doses)
Table 94. South America RNA Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 95. South America RNA Vaccines Sales by Application (2021-2026) & (K Doses)
Table 96. Middle East & Africa RNA Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 97. Middle East & Africa RNA Vaccines Sales by Country (2021-2026) & (K Doses)
Table 98. Middle East & Africa RNA Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa RNA Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa RNA Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 101. Middle East & Africa RNA Vaccines Sales by Type (2021-2026) & (K Doses)
Table 102. Middle East & Africa RNA Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 103. Middle East & Africa RNA Vaccines Sales by Application (2021-2026) & (K Doses)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. RNA Vaccines Typical Distributors
Table 107. RNA Vaccines Typical Customers
List of Figures
Figure 1. RNA Vaccines Picture
Figure 2. Global RNA Vaccines Sales Market Share by Type in 2020
Figure 3. Individualized Cancer Treatment MRNA Vaccine
Figure 4. Infectious Disease Treatment MRNA Vaccine
Figure 5. Infection Prevention MRNA Vaccine
Figure 6. Global RNA Vaccines Sales Market Share by Application in 2020
Figure 7. Infectious Disease
Figure 8. Cancer
Figure 9. Other
Figure 10. Global RNA Vaccines Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 11. Global RNA Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey RNA Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global RNA Vaccines Sales (2016-2026) & (K Doses)
Figure 32. Global RNA Vaccines Production Capacity (2016-2026) & (K Doses)
Figure 33. Global RNA Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. RNA Vaccines Market Drivers
Figure 35. RNA Vaccines Market Restraints
Figure 36. RNA Vaccines Market Trends
Figure 37. Global RNA Vaccines Sales Market Share by Manufacturer in 2020
Figure 38. Global RNA Vaccines Revenue Market Share by Manufacturer in 2020
Figure 39. RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 RNA Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 RNA Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 42. Global RNA Vaccines Sales Market Share by Region (2016-2026)
Figure 43. Global RNA Vaccines Revenue Market Share by Region (2016-2026)
Figure 44. North America RNA Vaccines Revenue (2016-2026) & (USD Million)
Figure 45. Europe RNA Vaccines Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific RNA Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. South America RNA Vaccines Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa RNA Vaccines Revenue (2016-2026) & (USD Million)
Figure 49. Global RNA Vaccines Sales Market Share by Type (2016-2026)
Figure 50. Global RNA Vaccines Revenue Market Share by Type (2016-2026)
Figure 51. Global RNA Vaccines Price by Type (2016-2026) & (USD/Dose)
Figure 52. Global RNA Vaccines Sales Market Share by Application (2016-2026)
Figure 53. Global RNA Vaccines Revenue Market Share by Application (2016-2026)
Figure 54. Global RNA Vaccines Price by Application (2016-2026) & (USD/Dose)
Figure 55. North America RNA Vaccines Sales Market Share by Country (2016-2026)
Figure 56. North America RNA Vaccines Revenue Market Share by Country (2016-2026)
Figure 57. North America RNA Vaccines Sales Market Share by Type (2016-2026)
Figure 58. North America RNA Vaccines Sales Market Share by Application (2016-2026)
Figure 59. Europe RNA Vaccines Sales Market Share by Country (2016-2026)
Figure 60. Europe RNA Vaccines Revenue Market Share by Country (2016-2026)
Figure 61. Europe RNA Vaccines Sales Market Share by Type (2016-2026)
Figure 62. Europe RNA Vaccines Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific RNA Vaccines Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific RNA Vaccines Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific RNA Vaccines Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific RNA Vaccines Sales Market Share by Application (2016-2026)
Figure 67. South America RNA Vaccines Sales Market Share by Country (2016-2026)
Figure 68. South America RNA Vaccines Revenue Market Share by Country (2016-2026)
Figure 69. South America RNA Vaccines Sales Market Share by Type (2016-2026)
Figure 70. South America RNA Vaccines Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa RNA Vaccines Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa RNA Vaccines Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa RNA Vaccines Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa RNA Vaccines Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
mRNAワクチンの世界市場2018-2025 mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh…- 感染性ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body. Scope of the Report: This report focuses on the Infectious Vaccines in global market, especially in North America, Europe and Asia-Pacific, S…
- 世界のオーエスキー病ワクチン市場 2021：企業別、地域別、種類・用途別 The Aujeszky Disease Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- HPV治療ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Human papilloma virus (HPV) vaccines are used to protect against HPV infections. Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papillom…
- 口蹄疫用ワクチンの世界市場2018-2025 An drug that provide immunity to the FMD.Growing livestock population and increasing demand for animal products are some of the factors contributing to the increased adoption of these vaccines globally. Livestock and zoonotic diseases are increasing over the past few decades owing to factors such as…